Olympus Corp.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3201200007
JPY
1,408.00
31 (2.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.7 M

Shareholding (Dec 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company has declared negative results in Jan 70 after 3 consecutive negative quarters

  • INTEREST(HY) At JPY 7,625 MM has Grown at 84.89%
  • DEBT-EQUITY RATIO (HY) Highest at 5.31 %
  • PRE-TAX PROFIT(Q) At JPY 22,051 MM has Fallen at -46.18%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 2,276,894 Million (Large Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

14.18%

stock-summary
Price to Book

3.10

Revenue and Profits:
Net Sales:
261,045 Million
(Quarterly Results - Dec 2025)
Net Profit:
14,170 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.83%
0%
-28.83%
6 Months
-25.52%
0%
-25.52%
1 Year
-28.47%
0%
-28.47%
2 Years
-36.7%
0%
-36.7%
3 Years
-36.97%
0%
-36.97%
4 Years
-39.24%
0%
-39.24%
5 Years
-37.48%
0%
-37.48%

Olympus Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.58%
EBIT Growth (5y)
14.74%
EBIT to Interest (avg)
21.20
Debt to EBITDA (avg)
0.43
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.92
Tax Ratio
26.02%
Dividend Payout Ratio
19.42%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
22.60%
ROE (avg)
18.96%

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.91
EV to EBIT
11.51
EV to EBITDA
8.50
EV to Capital Employed
2.97
EV to Sales
2.17
PEG Ratio
0.06
Dividend Yield
0.03%
ROCE (Latest)
25.82%
ROE (Latest)
23.79%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 3.92% vs 6.21% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -47.70% vs 41.36% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "261,045.00",
          "val2": "251,192.00",
          "chgp": "3.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "56,970.00",
          "val2": "59,038.00",
          "chgp": "-3.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,343.00",
          "val2": "2,694.00",
          "chgp": "-13.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4,783.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14,170.00",
          "val2": "27,094.00",
          "chgp": "-47.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.40%",
          "val2": "170.80%",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 6.53% vs 6.16% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 336.73% vs -80.45% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "997,332.00",
          "val2": "936,210.00",
          "chgp": "6.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "252,494.00",
          "val2": "215,694.00",
          "chgp": "17.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,821.00",
          "val2": "5,819.00",
          "chgp": "-17.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-23,539.00",
          "val2": "-95,654.00",
          "chgp": "75.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117,800.00",
          "val2": "26,973.00",
          "chgp": "336.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.50%",
          "val2": "160.00%",
          "chgp": "2.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
261,045.00
251,192.00
3.92%
Operating Profit (PBDIT) excl Other Income
56,970.00
59,038.00
-3.50%
Interest
2,343.00
2,694.00
-13.03%
Exceptional Items
0.00
-4,783.00
100.00%
Consolidate Net Profit
14,170.00
27,094.00
-47.70%
Operating Profit Margin (Excl OI)
150.40%
170.80%
-2.04%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 3.92% vs 6.21% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -47.70% vs 41.36% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
997,332.00
936,210.00
6.53%
Operating Profit (PBDIT) excl Other Income
252,494.00
215,694.00
17.06%
Interest
4,821.00
5,819.00
-17.15%
Exceptional Items
-23,539.00
-95,654.00
75.39%
Consolidate Net Profit
117,800.00
26,973.00
336.73%
Operating Profit Margin (Excl OI)
186.50%
160.00%
2.65%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 6.53% vs 6.16% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 336.73% vs -80.45% in Mar 2024

stock-summaryCompany CV
About Olympus Corp. stock-summary
stock-summary
Olympus Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available